Evidence map›Paper›PMID 41963357›Full record

ArticleNPJ genomic medicine2026

Variants in the ciliopathy gene SCLT1 are associated with non-syndromic and syndromic retinal degeneration of variable severity.

Riccardo Sangermano, Kaoru Fujinami, Suk Ho Byeon, Emily M Place, Julien Navarro, Johanna Valensi, Samer Khateb, Eyal Banin, Christel Condroyer, Stephanie DiTroia and 5 more

Abstract read
In one paragraph

Article in NPJ genomic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Riccardo SangermanoOcular Genomics Institute, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
Kaoru FujinamiLaboratory of Visual Physiology, Division of Vision Research, National Institute of Sensory Organs, NHO Tokyo Medical Center, Tokyo, Japan.
Suk Ho ByeonInstitute of Vision Research, Department of Ophthalmology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Emily M PlaceOcular Genomics Institute, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
Julien NavarroSorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.
Johanna ValensiDepartment of Ophthalmology, Hadassah Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Samer KhatebDepartment of Ophthalmology, Hadassah Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Eyal BaninDepartment of Ophthalmology, Hadassah Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Christel CondroyerSorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.
Stephanie DiTroiaCenter for Mendelian Genomics, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.
Dror SharonDepartment of Ophthalmology, Hadassah Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Christina ZeitzSorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.
Isabelle AudoSorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.
Kinga M BujakowskaOcular Genomics Institute, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA. kinga_bujakowska@meei.harvard.edu.
Jinu HanInstitute of Vision Research, Department of Ophthalmology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea. jinuhan@yuhs.ac.

Funding

A powerful web-based discovery platform for rare disease geneticsR01HG009141 · NHGRI · BROAD INSTITUTE, INC. · PI QUINLAN, AARON R, REHM, HEIDI L · 2017 to 2020
$2.9M
Finding Missing Genetic Causality of Inherited Retinal DegenerationsR01EY035717 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI Kinga Bujakowska · 2024 to 2026
$2.1M
Agence Nationale de la Recherche within the Investissements d'Avenir program ANR-11-IDEX-0004-0Foundation Fighting Blindness EGI-GE-1218-0753-UCSDIHU FOReSIGHT ANR-18-IAHU-0001Korea Disease Control and Prevention Agency 2018-ER6902-02LABEX LIFESENSES ANR-10-LABX-65National Human Genome Research Institute, the National Eye Institute, and the National Heart, Lung and Blood Institute UM1HG008900National Research Foundation of Korea 2020R1C1C1007965NEI NIH HHS R01EY035717NHGRI NIH HHS R01 HG009141
6 · The paper itself

Abstract

Inherited retinal degenerations (IRDs) are a group of clinically and genetically heterogeneous blinding disorders. In this study, we describe five families clearly or which were presumed to be diagnosed with autosomal recessive non-syndromic IRD and one with mild syndromic IRD, in which affected probands carried rare bi-allelic variants in SCLT1, a gene previously associated with multiple autosomal recessive ciliopathies. Eight of the ten variants identified were novel; five variants affected splicing, including the known missense p.(Lys544Arg), detected in compound heterozygosity in three East Asian probands, and the novel, hypomorphic, deep-intronic variant c.290+2732A>G, leading to the inclusion of a 45-bp cryptic exon containing a premature termination codon. Analysis of the genomic data also revealed a large in-frame tandem duplication spanning exons 3-10, which was subsequently validated. Although no clear correlation was found between the severity of the SCLT1-associated phenotypes and the identified causal variants, this report expands the current knowledge of SCLT1-associated disease by enriching its mutational landscape and clearly supports its association with autosomal recessive non-syndromic IRD.

Identifiers

PMID41963357
PMCPMC13260799

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.